跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 40 条关于
“NURIX”
全部
40
临床试验
6
药物
3
机构
2
资讯
29
去年
Nurix Therapeutics Appoints Anil Kapur to Board, Plans Pivotal Trial for NX-5948
2年前
Nurix Therapeutics Outlines 2024 Strategic Priorities with Focus on Cancer and Autoimmune Diseases
去年
Nurix Therapeutics' BTK Degrader Shows Promise in Clinical Trials
10个月前
Nurix Therapeutics Strengthens Board with Former Pfizer and Seagen Executive Roger Dansey
去年
Nurix Therapeutics' BTK Degrader NX-5948 Receives EMA PRIME Designation for CLL/SLL
27天前
Nurix Therapeutics Appoints Wes Burwell as Chief Human Resources Officer to Support Commercialization Push
去年
Nurix Therapeutics Advances Bexobrutideg Phase III Program and Expands Protein Degrader Pipeline
2个月前
Nurix Therapeutics Pipeline Review: BTK Degraders and Targeted Protein Degradation Advance in B-Cell Malignancies
去年
Nurix Therapeutics Presents Promising BTK Degrader Data at ASH 2024
上个月
Sanofi Initiates Phase 1 Trial of Oral STAT6 Degrader SAR448272, Triggering $10M Milestone Payment to Nurix
第 1 页,共 3 页
上一页
下一页